A study published recently in the AACR’s journal Cancer Discovery addresses the burgeoning question of the utility of high-throughput...
A hot topic in the field of cancer immunotherapy is: How do some cancers that initially respond to immune...
In a study published in the AACR’s journal Cancer Discovery in December, a team of researchers from the Perelman...
This post explores the challenges we face with anti-EGFR monoclonal antibody therapies and new strategies researchers have developed to...
Currently, anti-EGFR therapies are approved by the U.S. Food and Drug Administration for the treatment of non-small cell lung...
Through think tanks, special conferences, and its Pediatric Cancer Working Group, the AACR is taking steps to establish childhood...
Researchers at Weill Cornell Medical College have identified a mutation that may be responsible in mantle cell lymphoma for...
Each year, nearly 20,000 people in the United States are diagnosed with lung adenocarcinomas that harbor EGFR mutations. While...
For decades, experimental cancer drugs that did not provide measurable benefit to a significant number of patients in a...